BNO — Bionomics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- AU$14.69m
- -AU$15.40m
- AU$0.26m
Annual cashflow statement for Bionomics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2018 June 30th | 2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 8.2 | 6.57 | 7.48 | 2.92 | 0 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -20.5 | -15.6 | -3.9 | -7.54 | -21.8 |
| Capital Expenditures | -0.487 | -0.099 | -0.008 | -0.001 | -0.002 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.569 | 0.297 | -0.187 | -0.079 | 0.623 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.081 | 0.198 | -0.195 | -0.08 | 0.622 |
| Financing Cash Flow Items | — | -0.42 | -0.33 | -0.415 | -5.72 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.63 | 4.35 | -5.36 | 31.6 | 27 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -17.9 | -10.9 | -9.41 | 23.9 | 5.07 |